Total Payments
$620,491
2024 Payments
$125,901
Companies
48
Transactions
1,972
Medicare Patients
10,149
Medicare Billing
$823,767
Payment Breakdown by Category
Other$471,187 (75.9%)
Consulting$86,715 (14.0%)
Food & Beverage$38,652 (6.2%)
Travel$23,216 (3.7%)
Education$722.08 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $420,522 | 218 | 67.8% |
| Consulting Fee | $86,715 | 42 | 14.0% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $42,490 | 25 | 6.8% |
| Food and Beverage | $38,652 | 1,526 | 6.2% |
| Travel and Lodging | $23,216 | 144 | 3.7% |
| Compensation for serving as faculty or as a speaker for a medical education program | $6,875 | 2 | 1.1% |
| Honoraria | $1,300 | 2 | 0.2% |
| Education | $722.08 | 13 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $94,753 | 273 | $0 (2024) |
| Dermavant Sciences, Inc. | $79,240 | 102 | $0 (2024) |
| Lilly USA, LLC | $65,738 | 190 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $62,787 | 208 | $0 (2024) |
| Galderma Laboratories, L.P. | $59,745 | 115 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $56,290 | 196 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $52,600 | 66 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $28,491 | 47 | $0 (2024) |
| PFIZER INC. | $25,325 | 61 | $0 (2024) |
| Incyte Corporation | $20,596 | 53 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $125,901 | 310 | Arcutis Biotherapeutics, Inc. ($40,094) |
| 2023 | $148,291 | 323 | Dermavant Sciences, Inc. ($39,909) |
| 2022 | $98,555 | 255 | Lilly USA, LLC ($30,785) |
| 2021 | $72,701 | 191 | AbbVie Inc. ($18,820) |
| 2020 | $46,846 | 154 | AbbVie Inc. ($12,488) |
| 2019 | $47,363 | 275 | Novartis Pharmaceuticals Corporation ($18,958) |
| 2018 | $40,395 | 244 | Novartis Pharmaceuticals Corporation ($18,209) |
| 2017 | $40,440 | 220 | Allergan Inc. ($14,875) |
All Payment Transactions
1,972 individual payment records from CMS Open Payments — Page 1 of 79
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Dermatology | ||||||
| 12/23/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Dermatology | ||||||
| 12/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Immunology | ||||||
| 12/19/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $2.45 | General |
| Category: DERMATOLOGY | ||||||
| 12/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Immunology | ||||||
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.66 | General |
| Category: Immunology | ||||||
| 12/13/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.47 | General |
| Category: Immunology | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,350.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | Incyte Corporation | OPZELURA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,900.00 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $4.59 | General |
| 12/03/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/28/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Consulting Fee | Cash or cash equivalent | $1,100.00 | General |
| Category: Dermatology | ||||||
| 11/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $113.53 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Immunology | ||||||
| 11/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 2,862 | 5,170 | $1.1M | $227,134 |
| 2022 | 21 | 2,553 | 4,480 | $747,346 | $211,871 |
| 2021 | 21 | 2,330 | 4,041 | $527,110 | $197,755 |
| 2020 | 22 | 2,404 | 4,084 | $450,999 | $187,007 |
Total Patients
10,149
Total Services
17,775
Medicare Billing
$823,767
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 849 | 1,160 | $335,390 | $73,779 | 22.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 498 | 671 | $147,560 | $28,785 | 19.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 234 | 270 | $91,287 | $20,201 | 22.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 174 | 199 | $81,773 | $18,345 | 22.4% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 58 | 68 | $68,017 | $16,009 | 23.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 161 | 179 | $67,062 | $14,922 | 22.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 360 | 2,019 | $44,622 | $10,777 | 24.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 141 | 141 | $50,541 | $10,519 | 20.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 38 | 43 | $23,826 | $5,732 | 24.1% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 39 | 47 | $37,689 | $4,933 | 13.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $16,532 | $3,909 | 23.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 73 | 80 | $14,519 | $3,113 | 21.4% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 17 | 17 | $9,994 | $2,592 | 25.9% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 16 | 17 | $10,039 | $2,494 | 24.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 37 | 50 | $8,328 | $2,125 | 25.5% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 13 | 14 | $12,473 | $1,819 | 14.6% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 12 | 12 | $5,945 | $1,424 | 24.0% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 16 | 17 | $6,748 | $1,401 | 20.8% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 11 | 12 | $5,013 | $1,251 | 25.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 28 | 28 | $6,426 | $1,176 | 18.3% |
| 69100 | Biopsy of ear | Office | 2023 | 16 | 16 | $5,004 | $987.85 | 19.7% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 19 | 22 | $4,114 | $795.52 | 19.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 21 | 57 | $179.53 | $43.16 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 764 | 1,033 | $234,150 | $68,001 | 29.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 456 | 601 | $108,399 | $27,823 | 25.7% |
About Dr. Ronald Bernardin, MD
Dr. Ronald Bernardin, MD is a Dermatology healthcare provider based in Voorhees, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1164409819.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ronald Bernardin, MD has received a total of $620,491 in payments from pharmaceutical and medical device companies, with $125,901 received in 2024. These payments were reported across 1,972 transactions from 48 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($420,522).
As a Medicare-enrolled provider, Bernardin has provided services to 10,149 Medicare beneficiaries, totaling 17,775 services with total Medicare billing of $823,767. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Aerospace Medicine
- Location Voorhees, NJ
- Active Since 12/23/2005
- Last Updated 02/24/2015
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1164409819
Products in Payments
- SKYRIZI (Biological) $89,808
- VTAMA (Drug) $79,240
- TALTZ (Drug) $63,951
- COSENTYX (Biological) $51,438
- AKLIEF (Drug) $49,381
- Zoryve (Drug) $40,094
- DUOBRII (Drug) $25,989
- Sotyktu (Drug) $21,474
- EUCRISA (Drug) $20,993
- OPZELURA (Drug) $20,596
- WYNZORA (Drug) $19,763
- Otezla (Drug) $17,693
- ARAZLO (Drug) $11,752
- SILIQ (Drug) $7,665
- ELIDEL (Drug) $7,115
- ONEXTON (Drug) $6,881
- ACZONE (Drug) $6,494
- LUZU (Drug) $5,287
- EPIDUO FORTE (Drug) $5,239
- RHOFADE (Drug) $3,677
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Voorhees
David Finkelstein, Md, MD
Dermatology — Payments: $25,091
Dermatology $25,091
Terry Rollins, M.d, M.D
Dermatology — Payments: $7,209
Dermatology $7,209
Dr. Lauren Okon, Md, MD
Dermatology — Payments: $6,453
Dermatology $6,453
Bennett Schwartz, Md, MD
Dermatology — Payments: $1,598
Dermatology $1,598
Dr. Koulin Chou, M.d, M.D
Dermatology — Payments: $1,084
Dermatology $1,084